An MRI enterography is mostly a long drink and a longer wait, with a comparatively short scan at the end. You fast, you drink somewhere around a litre to a litre and a half of a faintly sweet liquid over about an hour, you get a cannula, and then you lie in the scanner for roughly 20 to 45 minutes while a voice tells you when to breathe in and hold it. Partway through, you are usually given an injection to stop your bowel moving and a contrast dye. Afterwards, the drink tends to go straight through you.
None of that is dangerous for most people, but very little of it is explained well in advance. The top complaint in the Crohn's threads we read was not the scan. It was that nobody warned them the drink is effectively a laxative, that the injection can make you feel sick in seconds, or that they would spend the rest of the day near a toilet. One of the most-discussed threads, with over a hundred replies, opens with a person who drove straight home after the scan and barely made it to the bathroom, and that experience is repeated again and again underneath it.
This guide goes through the day in order, then covers the part the radiology leaflets skip entirely: what the report words mean, what the scores are, and what the test can and cannot tell you. It is written for people with Crohn's disease or suspected Crohn's, which is who this test is mostly for. It is general information, not a substitute for the instructions your own imaging department sends you. Where their sheet disagrees with this page, follow their sheet.
The short answer: what actually happens, in order
Here is the typical sequence, pieced together from a European technical consensus, three sets of hospital or charity patient instructions, and the lived experience in the Crohn's forums. Your unit may differ in the details.
- Fasting beforehand, usually for several hours.
- Arrive early, often an hour before your scan slot, to start drinking.
- Drink the contrast over roughly 45 to 60 minutes, often in two to four cups or bottles at timed intervals, sometimes while walking around.
- Cannula placed in a vein in your arm or hand.
- Into the scanner, lying on your back or your front, with a pad or coil strapped over your abdomen and headphones or earplugs on.
- A first set of images to check the fluid has reached the end of the small bowel.
- A bowel-relaxing injection through the cannula, sometimes split into two doses.
- More images with repeated breath-holds.
- A contrast injection (gadolinium) for the final images.
- Out, dressed, and near a toilet. Most people can eat and drink normally straight away.
The whole appointment is typically a couple of hours or more. The scan itself is the shortest part.
Why this test, and not just a colonoscopy
An MRI enterography (MRE) is ordered because it can see things a camera cannot. A colonoscopy looks at the inside surface of the colon and, if the scope reaches, the last few centimetres of the small bowel. Crohn's disease can affect any part of the gut, including metres of small bowel that no standard scope reaches, and it inflames the whole thickness of the bowel wall rather than just the lining. MRE shows the full wall, the fat and blood vessels around it, and complications that sit outside the lining, such as narrowings, fistulas and abscesses.
How good is it? The best evidence comes from METRIC, a multicentre trial at eight UK hospitals funded by the UK's NIHR Health Technology Assessment programme. In 284 people with newly diagnosed Crohn's disease or a suspected relapse, MRE detected the presence of small bowel disease with 97% sensitivity and correctly mapped its extent in 80%, both significantly better than small bowel ultrasound (92% and 70%). Specificity for extent was 95% for MRE against 81% for ultrasound. There were no serious adverse events (Taylor 2018).
Why not a CT scan? CT enterography gives similar diagnostic accuracy. A meta-analysis of six studies and 290 patients found pooled sensitivity for active small bowel Crohn's of 87.9% for MRE and 85.8% for CT, with no statistically significant difference between them (Qiu 2014). The difference is radiation. In a study of people with Crohn's at one tertiary centre, CT accounted for 77.2% of all diagnostic radiation received, the mean cumulative dose was 36.1 mSv, and 15.5% of patients exceeded 75 mSv (Desmond 2008). For a disease that is often diagnosed young and imaged repeatedly for decades, MRE's lack of ionising radiation is the main reason it is preferred where available. A couple of people in the threads mention being offered a choice and picking CT because it is faster; that is a legitimate trade-off to discuss, not a wrong answer.
Why not only a colonoscopy? Because the two tests are strong in different places. In the PROFILE trial, which paired colonoscopy and small bowel MRI in 285 people with Crohn's at baseline, MRI identified only 18 of the 143 ulcerated segments that colonoscopy found. But people who went on to need abdominal surgery had higher baseline MRI scores, while their colonoscopy scores did not differ from those who avoided surgery. The authors concluded MRI should be considered complementary to colonoscopy, not a replacement (Bhandari 2026). PROFILE was funded by Wellcome.
The latest European guidance reflects that. According to a published radiological review of the 2025 ECCO-ESGAR-ESP-IBUS guideline, MRE and intestinal ultrasound are now recognised as co-first-line tools for diagnosis and monitoring, with MRE preferred for baseline staging and complex complications and ultrasound for frequent follow-up (Vlašiček 2026). We could not obtain the full text of the guideline itself (Kucharzik 2025), so we are relying on that review's summary of it. The US consensus from the Society of Abdominal Radiology and the American Gastroenterological Association similarly recommends cross-sectional enterography at diagnosis of Crohn's and considers it for monitoring (Bruining 2018).
If you are having a colonoscopy as well, the preparation is completely different and much harder; our guide to colonoscopy prep with Crohn's covers that separately. One Reddit poster described having an MRE on one day and starting colonoscopy prep the moment they came out of the scanner. If you have any say in the scheduling, it is worth asking whether the two can be spaced apart.
Before the day: fasting, medicines, metal and the questions they will ask
Fasting. Almost every unit asks for an empty stomach, because food in the small bowel blurs the images and dilutes the drink. How long varies. A US university protocol asks for four hours (UIC protocol); an IBD charity's patient guide says about six (Robbie's Rainbow); a UK hospital leaflet says the stomach and small bowel must be empty and sends a separate dietary sheet (RUH Bath leaflet). Use your own unit's number.
No laxative clear-out, as a rule. This surprises people who have done colonoscopy prep. The European consensus from the radiology societies ESGAR and ESPR, a 125-statement document on how these scans should be performed, specifically does not recommend a laxative bowel preparation for routine MRE (Taylor 2017). The UK leaflet notes that a mild laxative is sometimes prescribed, so again, go by what you are sent.
Medicines. The UK leaflet says to continue your usual medication and to contact the department if you use insulin. We would add: do not stop or change anything because of the scan unless the department or your IBD team tells you to. If you are unsure about a particular medicine, ring and ask.
Metal and implants. You will fill in a safety questionnaire about implants, devices and metal fragments. Take it seriously and answer it fully. One person in the threads had their scan cancelled on the day after a metal check flagged something from a previous procedure. If you have had surgery involving clips, staples, stents or devices, find out what was used before the day.
Kidneys. If you have known kidney disease, say so when the scan is booked, because it affects decisions about the gadolinium dye (more on that below).
Pregnancy. Tell the department if you are or might be pregnant. The UK leaflet notes there is no evidence that MRI is unsafe in pregnancy but that as a precaution they only scan pregnant patients when it is essential. Gadolinium in pregnancy is a separate question: a US Medicaid cohort of 5,991 qualifying pregnancies found fetal or neonatal death in 1.4% of both the gadolinium and non-gadolinium MRI groups (adjusted relative risk 0.73, 95% CI 0.34 to 1.55), which is reassuring on acute outcomes, though the authors note subacute outcomes were not evaluated (Winterstein 2023). That is a conversation for your team, not a decision to make from a single study.
A stoma. If you have an ileostomy, the European consensus recommends plugging the stoma before you drink the contrast, and suggests that in people with a major small bowel resection, scanning earlier (for example at 30 minutes) may be advisable (Taylor 2017). It admits there is no direct evidence for plugging. Ask the department how they handle it before the day; if you are new to an ileostomy, our guide to foods that cause ileostomy blockage is a useful companion for the day of fasting and drinking.
Intolerances. The UK leaflet asks people who are lactose intolerant to contact the department before the scan. Some oral contrast recipes include lactulose, a sugar made from lactose, and the European consensus lists lactulose among acceptable agents. If you know you react badly to particular sugars or sugar alcohols, ask what your unit uses. You may not have a choice, but knowing in advance helps you plan.
The drink: what it is, why there is so much of it, and why it goes straight through you
The drink is not a dye in the usual sense. Its job is mechanical: to fill and stretch the small bowel so the walls separate and can be measured. A collapsed loop of bowel can look thickened when it is not, or hide thickening that is there. In the words of the METRIC team, poor distension "can both conceal or mimic disease" (Bhatnagar 2022).
What is in it. The European consensus does not name one preferred agent. It lists mannitol (with or without locust bean gum), polyethylene glycol (PEG), sorbitol and lactulose among recommended options, sets the optimal volume at 1,000 to 1,500 ml, and recommends drinking it over 46 to 60 minutes in people without a major small bowel resection (Taylor 2017). Units then use their own recipe or a commercial product. The UIC protocol uses three 450 ml bottles over 60 minutes, aiming for one bottle every 20 minutes. The UK leaflet describes about 1.5 litres over roughly 40 minutes that "tastes like slightly sugary water".
People in the threads describe everything from a lemony flat-soda taste to apple juice to plain water with a metallic edge. Several were given a commercial flavoured drink; others remembered barium mixtures from years ago. Many said it was far easier to get down than colonoscopy prep, and a minority said the reverse.
Why it acts as a laxative. Mannitol and sorbitol are sugar alcohols, and PEG and lactulose are also poorly absorbed. They stay in the gut and hold water there by osmosis. A review of MRI gut-imaging research describes it vividly: 40 minutes after drinking 350 ml of a glucose solution, when 250 ml had left the stomach, the small bowel held only about 50 ml of water because the glucose had been absorbed; at the same point after 250 ml of mannitol had left the stomach, the small bowel held nearly 400 ml, a net secretion of about 150 ml (Spiller 2019). That is exactly the effect the radiologist wants for the pictures, and exactly why a litre or more of it produces urgent, watery stools a short time later. The same review describes another experiment in which most of the mannitol appeared to be fermented in the colon rather than passing through as water, which fits the other common report in the threads: a lot of gas.
If you have IBS alongside Crohn's, or know that sugar alcohols set you off, this will not be news. Our explainer on sorbitol as an IBS trigger covers why polyols hit some guts harder than others. It is a one-off exposure, not a diet, but it helps to know why your body reacts the way it does.
Mannitol or PEG: does it matter? Not much, on the best evidence. In an observational study of patients recruited to METRIC, overall distension was rated good or excellent in 54% of 68 people given mannitol and 46% of 37 given PEG, a difference that was not statistically significant. Mannitol filled the upper small bowel (the jejunum) better: 40% against 14% rated good or excellent. Side effects were broadly comparable, although fullness was rated "very tolerable" more often with mannitol (44% of 84 respondents) than with PEG (27% of 45) (Bhatnagar 2022). The study was retrospective, involved only the two agents those centres used, and was funded by the same public research programme as METRIC.
Practical tips people describe, none of which has been tested in a trial:
- Drink it cold, and through a straw.
- Pace it to the schedule rather than chugging, since several people found speed triggered the nausea.
- Walk around between cups. The charity guide recommends moving around between cups "to help the liquid slosh through your bowel", and one person was told by a technologist that not moving can leave the bowel under-filled.
- Suck a boiled sweet or lollipop between cups to change the taste. Ask first whether that is allowed, since you are fasting.
- Use the toilet before you go into the scanner, even if you have only a mild urge. It is much easier than stopping mid-scan.
What if you cannot finish the drink?
Tell the radiographer, and do not force yourself to the point of vomiting. This is one of the most common fears in the threads, and one person described being told that vomiting would get the scan cancelled. The evidence is more forgiving than that.
In the METRIC sub-study, the researchers compared people who drank a litre or less of mannitol with those who drank more. Neither the distension quality nor the side-effect profile differed between the two groups (Bhatnagar 2022). The European consensus notes evidence that examinations of reasonable quality can be achieved with as little as 450 ml, while also citing a study in ten healthy volunteers that found poorer distension below 1,000 ml. The committee could not reach consensus on a minimum volume and says that in practice it is judged case by case (Taylor 2017).
The lived experience matches. Across two of the threads, multiple people said they managed one and a half or two of three bottles, told the staff, and were scanned anyway, with reports that described the bowel as adequately seen. At least two people found that their report said "suboptimal small bowel distension" even though they had finished everything. In that thread, the report still went on to describe the terminal ileum as normal and rule out a stricture or abscess. Suboptimal distension does not mean the scan failed; it means the radiologist is flagging that some loops were less stretched than ideal, which slightly lowers confidence in those segments.
Anti-sickness medicine. Several people with a fear of vomiting said they asked their doctor for an anti-sickness prescription before the scan and found it helped. That is a reasonable conversation to have with the team who ordered the test, well in advance, because the department may need to know and it needs to be prescribed for you. Do not take something you have not been prescribed for this purpose.
The injections: the cannula, the bowel relaxant and the gadolinium
The bowel relaxant: why it is given, and why it can make you feel sick
Your small bowel moves constantly, and movement blurs the pictures. So partway through the scan, most units inject a drug that temporarily stops that movement. There are two in common use:
- Hyoscine butylbromide (often sold as Buscopan), an antispasmodic.
- Glucagon, a hormone that relaxes the gut muscle.
The European consensus recommends hyoscine butylbromide intravenously as the first-line agent and glucagon as the second-line agent when the first cannot be given or is unavailable. It also recommends giving the relaxant before the motion-sensitive sequences and accepts either a single or a split dose (Taylor 2017). In the Reddit threads, people describing US scans mostly mention glucagon, while people in the UK and Australia mostly mention Buscopan. We could not find a source that settles why, so treat that as an observation from the threads only.
How long does the effect last? Only a short time, which is why the injection comes midway rather than at the start. In a study of ten healthy volunteers, intravenous hyoscine produced aperistalsis lasting a mean of 6.8 minutes and failed to fully stop movement in half the cases, while glucagon always succeeded and lasted 18.3 minutes (Froehlich 2009). A second volunteer study of six people found intravenous effects began after about 85 seconds with hyoscine and 65 seconds with glucagon, and ended after about 21 and 23 minutes respectively (Gutzeit 2012). Those two small studies disagree substantially about how long hyoscine lasts, and we could not reconcile them from the abstracts; they used different measurement methods and very few people. The European consensus notes the volunteer data favouring glucagon but found no evidence it improves diagnostic accuracy.
Side effects. This is where most of the nausea stories come from.
- Glucagon and nausea. In a study of children having MR enterography, 24 of 50 (48%) reported glucagon-related nausea and 4 vomited. The authors also found glucagon improved bowel visualisation and added an average of 13.7 minutes to the examination (Dillman 2013). Those were children, and adults may differ. In a separate adult population, 541 people having screening CT colonography, nausea was the most frequently reported side effect of glucagon (13%), while dry mouth was the most common with hyoscine (15%) (de Haan 2012). In that study, glucagon was given only to people for whom hyoscine was unsuitable, which is a different group, and the figures come from a different procedure.
- Hyoscine and your eyes. The UK leaflet warns that the muscle relaxant may cause blurred vision and a dry mouth, that these soon wear off, and that you should not drive for 30 minutes after the injection (RUH Bath leaflet). If your unit uses it, arrange your journey home with that in mind.
The threads are full of people who felt a wave of nausea within seconds of the glucagon going in. Some described it passing in under a minute; a few vomited in the scanner. Things people said helped: telling the staff in advance that they had been sick last time, asking to be told when the injection was coming, and asking for it to be given slowly. One person noticed the nausea was milder when the injection was given into a muscle rather than through the drip. Whether any of that is possible depends on your unit's protocol, but asking costs nothing.
Gadolinium: what it is and the safety questions people raise
Near the end of the scan, most units inject a gadolinium-based contrast agent through the cannula. Inflamed bowel wall takes up more of it and lights up on the images, which is where report phrases like "hyperenhancement" come from. Some people feel a cold sensation up the arm or a brief strange taste; one person in the threads felt nauseous for about 30 seconds. The UK leaflet notes a slight risk of an allergic reaction and says staff are there to manage it. One commenter described a severe reaction on their first exposure and was careful to say it is very rare.
Kidneys. The serious historical concern was nephrogenic systemic fibrosis in people with advanced kidney disease. Joint consensus statements from the American College of Radiology and the National Kidney Foundation state that the risk from the modern group II agents is thought to be very low, with zero events after 4,931 administrations to patients with an eGFR below 30 (Weinreb 2021). If you have kidney disease, the department will weigh this with you.
Brain deposits. People who have many MRIs over a lifetime of Crohn's reasonably ask about reports of gadolinium staying in the brain. A summary of evidence from the International Society for Magnetic Resonance in Medicine confirms that gadolinium deposits have been found in brain tissue, including with the more stable macrocyclic agents, but states that the clinical significance, if any, is unknown and that there are no data in humans or animals showing adverse clinical effects from these deposits (Gulani 2017). That is an honest "unknown", not an all-clear and not a proven harm.
Can the scan be done without it? Sometimes. A study from the group that developed the simplified MaRIA score (explained below) validated it without gadolinium-enhanced sequences in 50 people starting biologics, 39 of whom had paired MRI and colonoscopy after 46 weeks. It detected active disease with an area under the curve of 0.92 (Capozzi 2020). That is one research group validating its own score, and whether a non-contrast scan is appropriate depends on the question being asked. It is a reasonable thing to raise with your team if you are worried about repeated exposure. It is not a reason to refuse contrast on the day without that conversation.
Inside the scanner: position, breath-holds, noise and time
Front or back. The European consensus says either prone (face down) or supine (face up) positioning is acceptable. There is some evidence that lying prone distends the bowel better, but no strong evidence it improves diagnostic accuracy, and the consensus acknowledges that some people find lying prone difficult (Taylor 2017). The UK leaflet asks patients to lie on their front "if possible". The charity guide says you will most likely lie on your back. If lying on your front is painful because of your abdomen, your back or a stoma, say so. In the threads, the prone position was one of the most complained-about parts of the whole day.
Breath-holds. You will be asked, again and again, to breathe in, breathe out and hold. The charity guide says each set of pictures takes around five minutes and that holds are short, not the whole five minutes, and suggests practising lying still and holding your breath at home. People who struggled with the holds, especially after surgery or when anaemic, found that telling the radiographer helped; some units can adjust the timing. One person suggested asking the radiographer to explain what each sequence is and how long it will run.
Arms. Some units ask you to put your arms above your head, which gets uncomfortable over 30 minutes or more. Others let you keep them by your sides. Ask whether you can lower them between sequences.
Noise. It is loud. You will get earplugs or headphones, often with music or a radio station. Several people recommended asking for both.
Time. The European consensus recommends keeping the total acquisition time for adult MRE to around 30 minutes or less (Taylor 2017). The UK leaflet says approximately 20 to 30 minutes. The charity guide says 30 to 60 minutes and "about 1,000" pictures in total. The Reddit thread that asked this directly got answers from about 15 minutes to over an hour in the scanner, with a newer machine and a smaller protocol at the short end, and total time in the department of one and a half to three hours (MRI length thread). Glucagon itself can add time: 13.7 minutes on average in the paediatric study above.
Claustrophobia. You are alone in the room, but the radiographer can see, hear and speak to you throughout, and you will have a call button. You can stop the scan, though the threads are honest that it may mean redoing part of it. In a randomised trial of 226 people who described themselves as claustrophobic, 189 (83.6%) completed their MRI. Immersive video glasses made no difference to anxiety compared with person-centred nursing care alone, and the authors credited the person-centred approach for the high completion rate (Diaz-Membrives 2026). The abstract also reports that "previously 49.7% couldn't complete" an MRI, which we could not interpret with confidence from the abstract alone. The practical point stands: tell the department in advance, ask about going in feet first, and if you think you will need a sedative, raise it with the doctor ordering the scan well beforehand, because it has to be prescribed and arranged.
Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.
Afterwards: plan the rest of your day around a toilet
The single most consistent piece of advice across every thread we read was: do not plan anything for the rest of the day. People described being caught out at a coffee shop with one toilet, on the drive home, at a hotel valet stand and at a wedding-anniversary film. The drink is a laxative and it behaves like one.
What the sources say:
- The UK leaflet says the drink "may cause some short lived diarrhoea", suggests waiting near a toilet in the department before going home, and says you can eat and drink normally as soon as the examination is finished (RUH Bath leaflet).
- The METRIC sub-study found something less comfortable. Abdominal pain and diarrhoea were generally rated less tolerable two days after the scan than immediately after it, for both mannitol and PEG. For example, abdominal pain was rated "very tolerable" by 61% of mannitol recipients straight after the scan but by only 31% two days later (Bhatnagar 2022). Only 75% and 56% of the two volume groups returned the delayed questionnaire, so the people who replied may have been the ones with more to report. Even so, it suggests the effects do not always clear by teatime.
Practical things people wish they had known:
- Bring a spare set of clothes, and consider wearing a pad or incontinence underwear for the journey home. One nurse in a thread said small accidents in the machine are common and not a big deal to staff.
- Know where the toilets are before you go in, and use one before the scan starts.
- Do not drive for 30 minutes if you had hyoscine, and ideally have someone else drive if you live far away.
- Keep drinking fluids afterwards, especially if you have a stoma or a short bowel.
- Eat something plain when you feel ready.
Can it trigger a flare? This has not, as far as we could find, been studied directly. People in the threads describe everything from a few hours of diarrhoea to feeling as if they had flu and wiped out for a day, and a few felt their symptoms were stirred up for longer. If your usual symptoms have not settled within a few days, contact your IBD team rather than waiting for your results appointment.
Results: who tells you, and how long it takes
A radiologist, a doctor who specialises in reading scans, reviews the images and writes a report for whoever requested the test. That person then discusses it with you (RUH Bath leaflet). There is no standard turnaround. People in the threads describe hearing within a few days to around two weeks, often at a pre-booked follow-up.
Increasingly, people see the written report in a patient portal before anyone has explained it. That is where most of the anxious Reddit posts start. It is also where a gap between the report and the phone call can appear. In one thread, a person was told by a nurse that everything "looked great" while the report mentioned findings outside the bowel, including a hernia. A reply from someone with long-standing Crohn's put it well: the radiologist's job is to describe everything they see; it is the ordering doctor's job to decide what matters.
Incidental findings are common. MRE images most of your abdomen and pelvis, so reports often mention things unrelated to your bowel. How common depends heavily on how "incidental" is defined:
| Study | People | Extra-intestinal findings reported | Findings judged important |
|---|---|---|---|
| Jensen 2010 | 283 with known or suspected Crohn's | 25% | 6.0% of patients had important or incompletely characterised findings; 0.7% benefited from further work-up, 3.2% had unnecessary examinations |
| Lorusso 2021 | 182 with proven or suspected Crohn's | 38.5% | 11 of the 70 people with findings (16%) had clinically relevant ones |
| Herfarth 2009 | 1,006 referred for MRE, including 710 with IBD | 59.6% | 16.2% of all findings judged high significance; in the IBD group the most common major finding was an abscess |
A note on that Lorusso figure: its abstract says clinically relevant findings "were found in 16% of MR-E", but the numbers it gives (11 of 70 findings) make 16% a share of the people with findings, not of all 182 scans, where it would be about 6%. The Herfarth series also counted abscesses, which are Crohn's complications rather than unrelated surprises, so it is not measuring the same thing as the other two.
The takeaway: a report listing a cyst or a "likely haemangioma" in the liver is common and usually benign, but not every mention is trivial. If something in your report is not addressed at your follow-up, ask about it directly.
Decoding the report: what the words mean
Radiology reports for Crohn's are increasingly written using a standardised vocabulary developed by the Society of Abdominal Radiology with the American Gastroenterological Association and other experts, including recommended impression statements for the summary at the end (Bruining 2018; Guglielmo 2020). The glossary below explains the terms that come up most in the reports people post online. It explains what the words describe; it cannot tell you what your own report means for your treatment.
| Report phrase | What it describes |
|---|---|
| Wall thickening | The bowel wall measures thicker than normal. The simplified MaRIA score uses more than 3 mm as its threshold (Ordás 2019). Thickening can be inflammation, scar tissue, or both. |
| Mural hyperenhancement | The wall lights up more than expected after gadolinium. Alongside thickening, it is read as a sign of active inflammation (Bettenworth 2019). |
| Mural oedema, or T2 hyperintensity | Fluid in the bowel wall. Oedema is one of the four items in the simplified MaRIA score, and high T2 signal was associated with inflammation in studies checked against surgical specimens (Bettenworth 2019). |
| Mural stratification | The layers of the wall look distinct from each other after contrast. It appears in stricture imaging alongside hyperenhancement as a sign of inflammation (Bettenworth 2019). |
| Ulcers or ulceration | Breaks in the lining visible on imaging. MRI sees these far less well than a scope does. |
| Comb sign | Engorged blood vessels running to the inflamed bowel, which on imaging look like the teeth of a comb on the mesenteric side of the bowel (Ueda 2022). |
| Perienteric fat stranding | Inflammatory change in the fat around the bowel. The fourth item in the simplified MaRIA score. |
| Fibrofatty proliferation or creeping fat | Extra fat wrapping around the diseased bowel. Creeping fat is one of the features radiologists assess in Crohn's strictures (Bettenworth 2019). |
| Luminal narrowing | The channel inside the bowel is narrower than normal. |
| Upstream or prestenotic dilation | The bowel before a narrowing is widened, because contents back up. |
| Stricture | In general, a combination of wall thickening, luminal narrowing and upstream dilation (Bettenworth 2019). A 2025 Society of Abdominal Radiology update lowered the dilation threshold to 2.5 cm (from 3.0 cm) and now counts a narrowing a scope could not pass even without dilation (Dane 2025). |
| Skip lesions | Diseased segments separated by normal-looking bowel. |
| Fistula, sinus tract, abscess | Penetrating complications: an abnormal channel, a blind-ending track, or a collection of pus. |
| Suboptimal distension | Some loops were not as stretched as ideal, so the radiologist is slightly less confident about those segments. |
Why definitions matter. The Gut systematic review of stricture imaging found that the definitions used across studies were heterogeneous, even though accuracy for detecting a stricture was very high (Bettenworth 2019). The SAR consensus panel says more than half of people with Crohn's will develop strictures and changed its definitions so they would be identified sooner (Dane 2025). So a report from 2019 and one from 2026 may use "stricture" slightly differently. If a report says "probable" or "possible" stricture, ask what would make it definite.
The final paragraph, the impression, is the summary for your doctor. The SAR consensus recommends standard impression statements precisely so that this paragraph conveys what gastroenterologists and surgeons need (Bruining 2018). Whether the impression describes active inflammation, a stricture, or a penetrating complication such as a fistula matters far more to your treatment than any single millimetre measurement.
The scores: MaRIA and simplified MaRIA
Some reports, and many research papers, include a score. The two you are most likely to meet are the Magnetic Resonance Index of Activity (MaRIA) and its simplified version.
The simplified MaRIA was derived in 98 people and validated in 37. It gives points for four features: wall thickening over 3 mm, mural oedema, perienteric fat stranding and ulcers. The derivation paper reports that scores above 1 identified active segments with 90% sensitivity and 81% specificity, and scores of 2 or more detected ulcers with 85% sensitivity and 92% specificity (Ordás 2019). The later no-gadolinium validation by the same group describes its cutoff for active disease as "≥1" rather than "greater than 1" (Capozzi 2020). We could not reconcile those two wordings from the abstracts, so if your report quotes a score of exactly 1, ask how your team interprets it.
The honest context comes from a much larger, independent dataset. In the PROFILE trial, correlation between the simplified MaRIA and the colonoscopy score was only moderate (Spearman's rho 0.428), MRI found only 18 of 143 ulcerated segments, and a treatment difference that showed up clearly on colonoscopy did not show up on MRI at all (Bhandari 2026). Yet higher baseline MRI scores were associated with later surgery and the colonoscopy scores were not. The two findings sit together: MRI is weaker at the lining and stronger at the whole-wall picture that drives surgical outcomes.
"Can wall thickening go away?" Inflammation versus scar
This is the question that one thread asks directly, and the replies capture the real answer: thickening caused by inflammation can settle with treatment; thickening caused by scar tissue (fibrosis) generally does not respond to anti-inflammatory medicine.
The difficulty is telling them apart. Most strictures contain a mix of inflammatory cells, muscle thickening and fibrosis. The Gut systematic review, which only included studies where the whole bowel wall was later examined under a microscope, concluded that although conventional MRI, CT and ultrasound have been reported to distinguish inflammation from fibrosis and grade them, they are not sufficiently accurate for use in routine clinical practice (Bettenworth 2019). That review was funded by the Helmsley Charitable Trust. The radiological review of the 2025 European guideline similarly describes non-invasive separation of inflammatory and fibrotic strictures as an unmet need, with newer MRI and ultrasound techniques still under evaluation (Vlašiček 2026).
In practice, that is why a repeat scan after a change in treatment is often the most useful test of all. If a thickened, hyperenhancing segment becomes thinner and quieter on biologic therapy, much of it was inflammation. If it stays narrow and the upstream bowel stays dilated, scar tissue is more likely.
Transmural healing. When the whole thickness of the wall returns to normal on imaging, doctors call it transmural healing, and it is attracting attention as a treatment target. The 2026 review of the European guidance says the guideline incorporates transmural healing as an achievable therapeutic target, and describes it on MRE as a normal MaRIA or simplified MaRIA score. The evidence behind it:
- A systematic review of 46 studies and 5,530 patients found that healing was generally associated with fewer hospitalisations and surgeries, "especially" transmural healing, although only 13 studies reported transmural outcomes (Sands 2025). That review was funded by AbbVie, which makes Crohn's drugs, and AbbVie participated in interpreting the data.
- A cohort of 180 patients found transmural healing in 26.7%, with cumulative surgery rates of 0%, 2.3% and 7.0% at one, three and five years against 13%, 20.5% and 26.9% in those with no healing (Vuyyuru 2026). The reported hazard ratio for surgery was 0.01 with a 95% confidence interval of 0.00 to 0.35, which tells you the estimate rests on very few events in the healed group and is extremely imprecise. Differences in hospitalisation were not statistically significant. We could not read a funding statement for this study.
So "can it go away?" has a hopeful answer for inflammation and a less hopeful one for scar, and the scan alone often cannot say which you have. If your report shows thickening, the most useful question to ask is: "Do you think this is mostly inflammation or mostly scarring, and how will we know?"
MRE compared with the other tests you might be offered
| Test | What it sees best | Radiation | Preparation | Main limitation |
|---|---|---|---|---|
| MRI enterography | Whole small bowel, full wall thickness, fistulas, abscesses, strictures | None | Fasting, large oral drink, injections | Long appointment; weak at superficial ulcers |
| CT enterography | Similar diagnostic accuracy for small bowel activity | Yes | Fasting, oral drink | Cumulative radiation over years |
| Intestinal ultrasound | Wall thickness and blood flow in reachable segments | None | Varies by unit | Lower sensitivity for extent than MRE in METRIC; operator-dependent |
| Colonoscopy | Lining of the colon and terminal ileum; biopsies | None | Full laxative bowel prep, sedation | Cannot see most of the small bowel or outside the wall |
| Pelvic MRI | Perianal fistulas and abscesses | None | Varies by unit | A different scan; not the same as MRE |
Sources: METRIC for MRE versus ultrasound (Taylor 2018); the CT versus MRE meta-analysis (Qiu 2014); PROFILE for MRE versus colonoscopy (Bhandari 2026); and the 2025 guideline review, which describes pelvic MRI as the reference modality for perianal Crohn's (Vlašiček 2026).
If you have perianal disease, it is worth confirming whether you are booked for a pelvic MRI, an MRE, or both, since they are set up differently and one does not always answer the other's question.
A worked example: reading a report line by line
This is an invented report, written in the style of the ones people share online, to show how the pieces fit together. It is not a real patient.
Findings: Adequate small bowel distension. A 12 cm segment of distal ileum shows mural thickening to 7 mm with mural hyperenhancement and T2 hyperintensity. Engorged vasa recta (comb sign). Mild perienteric fat stranding. No upstream dilation. No fistula, sinus tract or abscess. The jejunum is normal. Incidental 8 mm simple cyst in the right lobe of the liver.
Impression: Active inflammatory small bowel Crohn's disease of the distal ileum, without stricture or penetrating complication.
Reading it:
- "Adequate distension" means the drink did its job; the radiologist is confident in what they saw.
- "12 cm segment of distal ileum" tells you where and how long. Length matters for surgical planning and for comparing scans over time.
- "Thickening to 7 mm, hyperenhancement, T2 hyperintensity, comb sign, fat stranding" is a cluster of signs that all point towards active inflammation, rather than a quiet, scarred segment. On the simplified MaRIA, thickening, oedema and fat stranding would each score.
- "No upstream dilation" is the key reassurance about obstruction: contents are getting through.
- "No fistula, sinus tract or abscess" rules out the penetrating complications.
- "Simple cyst in the liver" is an incidental finding of the kind that is usually benign; your doctor should still mention it.
- The impression is what drives the conversation: active inflammation, no stricture, no penetration. That is the category most likely to respond to medical treatment, and a repeat scan after treatment is the natural way to check.
A different report with the same thickening but "luminal narrowing with upstream dilation to 3.2 cm" and "minimal hyperenhancement" would lead to a very different conversation, about a stricture that may be mostly fibrotic.
Myths about MRI enterography
"If you throw up the drink, the test is ruined." Not necessarily. There is no agreed minimum volume, the METRIC sub-study found no distension difference above versus below a litre, and people in the threads describe being scanned after partial drinks. Vomiting a large amount may mean waiting and drinking more, which is why telling staff early is better than pushing through.
"The drink is a bowel prep." It is a distending agent, not a clear-out. The European consensus does not recommend a laxative bowel preparation for routine MRE. It does, however, act as a laxative afterwards.
"MRI can replace my colonoscopies." Not on current evidence. MRI missed most of the ulcers colonoscopy found in PROFILE, and current guidance treats the two as complementary.
"A normal MRE means I don't have Crohn's." MRE is very sensitive for small bowel disease, 97% in METRIC, but in PROFILE it missed most of the ulcers a colonoscopy found. A normal scan is strong evidence, not proof, and it is always read alongside your symptoms, bloods, calprotectin and any scope results. If your calprotectin is high but you feel fine, the scan is often part of how that gets investigated.
"Gadolinium is proven to damage your brain." Deposits exist; harm has not been shown. The honest answer is "unknown", which is a fair reason to ask whether each contrast dose is necessary, not a reason to panic.
"Wall thickening means permanent damage." Inflammatory thickening can resolve with treatment. Fibrotic thickening generally does not. Imaging cannot always tell which is which, so ask.
When to seek help promptly
Most after-effects are unpleasant but expected. Contact your IBD team or seek urgent care promptly if, after the scan, you have:
- Signs of an allergic reaction such as a rash, swelling of the face or lips, or difficulty breathing (call emergency services for breathing difficulty).
- Severe or worsening abdominal pain, repeated vomiting, a swollen abdomen and an inability to pass wind or stool, which can signal an obstruction, particularly if you have a known stricture.
- Fever, or diarrhoea with blood that is new or heavier than your usual pattern.
- Dizziness, very dark urine or an inability to keep fluids down, especially with a stoma or short bowel, where dehydration comes on faster.
- Eye pain or blurred vision that does not settle after hyoscine.
- Symptoms that remain worse than your normal after several days.
Separately, if you are waiting for an MRE because of new symptoms such as blood in your stool, unexplained weight loss, fevers, night-time symptoms or anaemia, do not let a scan date be the only plan. Tell your doctor promptly if those symptoms get worse while you wait.
Questions worth asking, briefly
We have a full guide to questions to ask your doctor about Crohn's disease, so this is only the scan-specific short list:
- Before: How long should I fast? Which drink do you use, and does it contain sugar alcohols or lactulose? Will I be face down? Which bowel relaxant do you use, and can I have something for nausea if I have been sick before? Do I need gadolinium this time?
- After: Is the thickening mostly inflammation or mostly scarring? Is there a stricture, and what would make it definite? Has anything changed since my last scan? Are there any incidental findings I should know about? When will we repeat it?
Tracking around the scan
Two things are worth writing down. First, how the day went: which drink, how much you managed, whether the injection made you sick and what helped. Next time, that note lets you ask for the adjustments that worked, rather than rediscovering them. Second, your symptoms in the weeks either side of the scan, because imaging is interpreted alongside how you have been. If you already keep a log, Clairop builds a one-page GI visit report with your symptom trend, bowel pattern, medication adherence and lab results, which puts the scan result in context at the follow-up. If you want to know which fields matter most to a gastroenterologist, our guide to the symptom tracker a doctor will actually read covers the handover.
The honest bottom line
An MRI enterography is a long, uncomfortable morning rather than a painful procedure, and almost all of the discomfort comes from the drink and the bowel-relaxing injection, not the scan. Knowing that in advance changes the day: you fast as instructed, drink at the pace you can manage and tell staff when you have hit your limit, warn them if you have felt sick before, and keep the afternoon free.
What you get in return is the most complete picture of your small bowel available without surgery, with no radiation. It is excellent at showing where Crohn's is, how far it extends and whether there are strictures, fistulas or abscesses. It is weaker at the fine detail of the lining, and it cannot yet reliably tell inflammation from scar. Read the report as a description, ask about the impression, and let the next scan, not the current millimetre count, tell you whether things are moving in the right direction.




